Lilly’s Covid-19 antibody helps patients rid their systems of virus sooner
A drug being developed by Eli Lilly helped sick patients rid their systems of the virus that causes Covid-19 sooner and may have prevented them from landing in the hospital, according to newly released data.
The drug is what is known as a monoclonal antibody, which experts view as being among the most likely technologies to help treat Covid-19. It’s a manufactured version of the antibodies that the body uses as part of its response to a virus.
Read Original Article: Lilly’s Covid-19 antibody helps patients rid their systems of virus sooner »
